Amira Pharmaceuticals, Inc. (extinct)

Amira Pharmaceuticals, Inc. (extinct)

Amira Pharmaceuticals, Inc. (extinct)

Overview
Date Founded

2005

Headquarters

9535 Waples Street,Suite 100,San Diego, CA 92121

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Paths to Amira Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Amira Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Bristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Transaction Advisors
Legal Advisor

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Investment Advisor

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Public Relations

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Legal Advisor

Advised onBristol-Myers Squibb Company purchases Amira Pharmaceuticals, Inc.

Investors
Details Hidden

Prospect Venture Partners focuses on investments in commercially attractive biomedical technology and life science companies that have management teams, proprietary products and innovative technology or services. They participate in new company incubations,seed, first and second venture financing rounds and expansion capital financings of later-stage private and public companies with proven business models. Initial investments range from $500,000 to $10 million with $10 million to $20 million invested over the life of a company. Prospect Venture Partners will serve as a lead investor or as a co-lead in a syndicate. The firm typically takes a seat on the boards of their portfolio companies.

Details Hidden

Founder at Foresite Capital Management LLC

Details Hidden

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation’s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amira Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amira Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amira Pharmaceuticals, Inc..